Epicardial and Pericoronary Adipose Tissue, Coronary Inflammation, and Acute Coronary Syndromes
-
Published:2023-11-21
Issue:23
Volume:12
Page:7212
-
ISSN:2077-0383
-
Container-title:Journal of Clinical Medicine
-
language:en
-
Short-container-title:JCM
Author:
Napoli Gianluigi1ORCID, Pergola Valeria2ORCID, Basile Paolo1ORCID, De Feo Daniele1ORCID, Bertrandino Fulvio1, Baggiano Andrea3ORCID, Mushtaq Saima3, Fusini Laura3ORCID, Fazzari Fabio3, Carrabba Nazario4ORCID, Rabbat Mark G.56, Motta Raffaella7ORCID, Ciccone Marco Matteo1, Pontone Gianluca3ORCID, Guaricci Andrea Igoren1ORCID
Affiliation:
1. University Cardiologic Unit, Interdisciplinary Department of Medicine, Polyclinic University Hospital, 70124 Bari, Italy 2. Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padua, 35122 Padua, Italy 3. Department of Perioperative Cardiology and Cardiovascular Imaging, Centro Cardiologico Monzino, IRCCS, 20138 Milan, Italy 4. Department of Cardiothoracovascular Medicine, Azienda Ospedaliero Universitaria Careggi, 50134 Florence, Italy 5. Division of Cardiology, Loyola University of Chicago, Chicago, IL 60611, USA 6. Edward Hines Jr. VA Hospital, Hines, IL 60141, USA 7. Radiology Unit, University Hospital of Padova, 35128 Padua, Italy
Abstract
Vascular inflammation is recognized as the primary trigger of acute coronary syndrome (ACS). However, current noninvasive methods are not capable of accurately detecting coronary inflammation. Epicardial adipose tissue (EAT) and pericoronary adipose tissue (PCAT), in addition to their role as an energy reserve system, have been found to contribute to the development and progression of coronary artery calcification, inflammation, and plaque vulnerability. They also participate in the vascular response during ischemia, sympathetic stimuli, and arrhythmia. As a result, the evaluation of EAT and PCAT using imaging techniques such as computed tomography (CT), cardiac magnetic resonance (CMR), and nuclear imaging has gained significant attention. PCAT-CT attenuation, which measures the average CT attenuation in Hounsfield units (HU) of the adipose tissue, reflects adipocyte differentiation/size and leukocyte infiltration. It is emerging as a marker of tissue inflammation and has shown prognostic value in coronary artery disease (CAD), being associated with plaque development, vulnerability, and rupture. In patients with acute myocardial infarction (AMI), an inflammatory pericoronary microenvironment promoted by dysfunctional EAT/PCAT has been demonstrated, and more recently, it has been associated with plaque rupture in non-ST-segment elevation myocardial infarction (NSTEMI). Endothelial dysfunction, known for its detrimental effects on coronary vessels and its association with plaque progression, is bidirectionally linked to PCAT. PCAT modulates the secretory profile of endothelial cells in response to inflammation and also plays a crucial role in regulating vascular tone in the coronary district. Consequently, dysregulated PCAT has been hypothesized to contribute to type 2 myocardial infarction with non-obstructive coronary arteries (MINOCA) and coronary vasculitis. Recently, quantitative measures of EAT derived from coronary CT angiography (CCTA) have been included in artificial intelligence (AI) models for cardiovascular risk stratification. These models have shown incremental utility in predicting major adverse cardiovascular events (MACEs) compared to plaque characteristics alone. Therefore, the analysis of PCAT and EAT, particularly through PCAT-CT attenuation, appears to be a safe, valuable, and sufficiently specific noninvasive method for accurately identifying coronary inflammation and subsequent high-risk plaque. These findings are supported by biopsy and in vivo evidence. Although speculative, these pieces of evidence open the door for a fascinating new strategy in cardiovascular risk stratification. The incorporation of PCAT and EAT analysis, mainly through PCAT-CT attenuation, could potentially lead to improved risk stratification and guide early targeted primary prevention and intensive secondary prevention in patients at higher risk of cardiac events.
Reference125 articles.
1. James, S., Camm, A.J., Lüscher, T.F., Maurer, G., and Serruys, P.W. (2018). The ESC Textbook of Cardiovascular Medicine, Oxford University Press. 2. Evolution of epidemiology and management of acute coronary syndromes in Abidjan: A cross-sectional study of 1011 patients;Yao;Ann. Cardiol. Angeiol.,2022 3. CT coronary angiography and exercise ECG in a population with chest pain and low-to-intermediate pre-test likelihood of coronary artery disease;Maffei;Heart,2010 4. Prognostic value of computed tomography coronary angiography in patients with chest pain of suspected cardiac origin;Maffei;Radiol. Med.,2011 5. Carotid intima media thickness and coronary atherosclerosis linkage in symptomatic intermediate risk patients evaluated by coronary computed tomography angiography;Guaricci;Int. J. Cardiol.,2014
|
|